RECURRENT AND DE NOVO GLOMERULAR DISEASE AFTER RENAL TRANSPLANTATION

1999234 citationsJournal Article

Authors

Sundaram Hariharan · Medical College of Wisconsin

Mark B. Adams

Daniel C. Brennan · Washington School of Psychiatry

Connie L. Davis · University of Washington

M. Roy First · University of Cincinnati

Christopher P. Johnson

Rosemary Ouseph · University of Louisville Hospital

V. Ram Peddi

Abstract

In conclusion, recurrent and de novo disease are associated with poorer long-term survival, and the relative risk of allograft loss is double. Significant impact on graft survival was seen with recurrent and de novo FSGS, membranoproliferative glomerulonephritis, and HUS/TTP.

Topics & Keywords

Renal Diseases and Glomerulopathies Renal Transplantation Outcomes and Treatments Complement system in diseases

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Transplantation

Volume 68, Issue 5, pp. 635-641

DOI: 10.1097/00007890-199909150-00007

Field-Weighted Citation Impact: 6.32